Search Results - "Hsu, Tiffany Y. T."
-
1
Coronavirus Disease 2019 Outcomes Among Recipients of Anti‐CD20 Monoclonal Antibodies for Immune‐Mediated Diseases: A Comparative Cohort Study
Published in ACR open rheumatology (01-03-2022)“…Objective Patients with immune‐mediated diseases treated with anti‐CD20 monoclonal antibodies may have worse coronavirus disease 2019 (COVID‐19) outcomes due…”
Get full text
Journal Article -
2
-
3
Assessing the Severity of COVID‐19 Lung Injury in Rheumatic Diseases Versus the General Population Using Deep Learning–Derived Chest Radiograph Scores
Published in Arthritis care & research (2010) (01-03-2023)“…Objective COVID‐19 patients with rheumatic disease have a higher risk of mechanical ventilation than the general population. The present study was undertaken…”
Get full text
Journal Article -
4
Association Between Race/Ethnicity and COVID‐19 Outcomes in Systemic Lupus Erythematosus Patients From the United States: Data From the COVID‐19 Global Rheumatology Alliance
Published in Arthritis care & research (2010) (01-01-2023)“…Objective To determine the association between race/ethnicity and COVID‐19 outcomes in individuals with systemic lupus erythematosus (SLE). Methods Individuals…”
Get full text
Journal Article -
5
The spliceosome is a therapeutic vulnerability in MYC-driven cancer
Published in Nature (London) (17-09-2015)“…Splicing factors such as BUD31 are identified in a synthetic-lethal screen with cells overexpressing the transcription factor MYC; oncogenic MYC leads to an…”
Get full text
Journal Article -
6
Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancer
Published in Cell (21-01-2021)“…Many oncogenic insults deregulate RNA splicing, often leading to hypersensitivity of tumors to spliceosome-targeted therapies (STTs). However, the mechanisms…”
Get full text
Journal Article -
7
MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis
Published in The Journal of clinical investigation (01-01-2014)“…Metabolic profiling of cancer cells has recently been established as a promising tool for the development of therapies and identification of cancer biomarkers…”
Get full text
Journal Article -
8
Teaching NeuroImage: Bilateral Middle Cerebellar Peduncle Stroke in Giant Cell Arteritis
Published in Neurology (04-01-2022)Get full text
Journal Article -
9
DMARD disruption, rheumatic disease flare, and prolonged COVID-19 symptom duration after acute COVID-19 among patients with rheumatic disease: A prospective study
Published in Seminars in arthritis and rheumatism (01-08-2022)“…To describe disease-modifying antirheumatic drug (DMARD) disruption, rheumatic disease flare/activity, and prolonged COVID-19 symptom duration among COVID-19…”
Get full text
Journal Article -
10
Coronavirus disease 2019 outcomes among patients with rheumatic diseases 6 months into the pandemic
Published in Annals of the rheumatic diseases (01-05-2021)“…In earlier studies, patients with rheumatic and musculoskeletal disease (RMD) who got infected with COVID-19 had a higher risk of mechanical ventilation than…”
Get more information
Journal Article -
11
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
Published in The New England journal of medicine (03-12-2020)“…This letter describes an immunocompromised patient who had persistent infection with SARS-CoV-2 over a period of months, despite several courses of remdesivir…”
Get full text
Journal Article -
12
Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry
Published in Annals of the rheumatic diseases (01-09-2021)“…To investigate baseline use of biologic or targeted synthetic (b/ts) disease-modifying antirheumatic drugs (DMARDs) and COVID-19 outcomes in rheumatoid…”
Get more information
Journal Article -
13
SARS-CoV-2 antibody response after COVID-19 in patients with rheumatic disease
Published in Annals of the rheumatic diseases (01-06-2021)Get more information
Journal Article -
14
Temporal trends in COVID-19 outcomes among patients with systemic autoimmune rheumatic diseases: from the first wave through the initial Omicron wave
Published in Annals of the rheumatic diseases (01-12-2022)“…To investigate temporal trends in incidence and severity of COVID-19 among patients with systemic autoimmune rheumatic diseases (SARDs) from the first wave…”
Get more information
Journal Article -
15
Response to: 'Correspondence on 'SARS-CoV-2 antibody response after COVID-19 in patients with rheumatic disease'' by C et al
Published in Annals of the rheumatic diseases (01-06-2023)Get more information
Journal Article -
16
Response to: 'COVID-19 in patients with rheumatic diseases: what is the real mortality risk?' by Marques et al
Published in Annals of the rheumatic diseases (01-08-2022)Get more information
Journal Article -
17
Obstetric outcomes in women with rheumatic disease and COVID-19 in the context of vaccination status
Published in Rheumatology (Oxford, England) (03-04-2023)“…Abstract Objective To describe obstetric outcomes based on COVID-19 vaccination status, in women with rheumatic and musculoskeletal diseases (RMDs) who…”
Get full text
Journal Article -
18
Development of a Prediction Model for COVID‐19 Acute Respiratory Distress Syndrome in Patients With Rheumatic Diseases: Results From the Global Rheumatology Alliance Registry
Published in ACR open rheumatology (01-10-2022)“…Objective Some patients with rheumatic diseases might be at higher risk for coronavirus disease 2019 (COVID‐19) acute respiratory distress syndrome (ARDS). We…”
Get full text
Journal Article -
19
Factors associated with severe COVID-19 in people with idiopathic inflammatory myopathy: results from the COVID-19 Global Rheumatology Alliance physician-reported registry
Published in Rheumatic & musculoskeletal diseases open (13-09-2022)“…ObjectivesTo investigate factors associated with severe COVID-19 in people with idiopathic inflammatory myopathy (IIM).MethodsDemographic data, clinical…”
Get full text
Journal Article -
20
The Oncogenic STP Axis Promotes Triple-Negative Breast Cancer via Degradation of the REST Tumor Suppressor
Published in Cell reports (Cambridge) (20-11-2014)“…Defining the molecular networks that drive breast cancer has led to therapeutic interventions and improved patient survival. However, the aggressive…”
Get full text
Journal Article